Midodrine
alpha-Adrenergic Agonist
NADAC/unit
$0.0729
No Shortage
Tier 1: 59.3%
13 Manufacturers
39 ANDAs
Midodrine stimulates alpha-adrenergic receptors, used for nasal congestion, glaucoma, or ADHD.
Active Shortages
2025-04-28 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-28 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-28 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-28 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-28 Shortage reported, Upsher-Smith Laboratories, LLC
Market Intelligence
2026-03-11 Class II Recall: The Harvard Drug Group LLC
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAPOTEX INCAUROBINDO PHARMA LTDBEIJING YILING BIO-ENGINEERING TECHNOLOGY CO LTDIMPAX PHARMACEUTICALSMANKIND PHARMA LTDMYLAN PHARMACEUTICALS INCNOVUGEN PHARMA MALAYSIA SDN BHDPH HEALTH LTDRUBICON RESEARCH LTDTHINQ PHARMA-CRO PRIVATE LTDXIROMED PHARMA ESPANA SLZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.